María Eugenia
Alonso Sarasquete
Investigadora desde null
Publicaciones en las que colabora con María Eugenia Alonso Sarasquete (96)
2024
-
Single-Cell DNA Sequencing and Immunophenotypic Profiling to Track Clonal Evolution in an Acute Myeloid Leukemia Patient
Biomedicines, Vol. 12, Núm. 1
2023
-
Clonal architecture and evolutionary history of Waldenström's macroglobulinemia at the single-cell level
Disease models & mechanisms, Vol. 16, Núm. 8
-
Minimal Residual Disease in Multiple Myeloma: Past, Present, and Future
Cancers, Vol. 15, Núm. 14
-
Polymorphisms within Autophagy-Related Genes as Susceptibility Biomarkers for Multiple Myeloma: A Meta-Analysis of Three Large Cohorts and Functional Characterization
International Journal of Molecular Sciences, Vol. 24, Núm. 10
2022
-
A Standardized Liquid Biopsy Preanalytical Protocol for Downstream Circulating-Free DNA Applications
Journal of Visualized Experiments, Vol. 2022, Núm. 187
-
Interlaboratory Analytical Validation of a Next-Generation Sequencing Strategy for Clonotypic Assessment and Minimal Residual Disease Monitoring in Multiple Myeloma
Archives of pathology & laboratory medicine, Vol. 146, Núm. 7, pp. 862-871
-
MYD88 Mutations: Transforming the Landscape of IgM Monoclonal Gammopathies
International Journal of Molecular Sciences, Vol. 23, Núm. 10
2021
-
6q deletion in Waldenström macroglobulinaemia negatively affects time to transformation and survival
British Journal of Haematology, Vol. 192, Núm. 5, pp. 843-852
-
Common gene variants within 3′-untranslated regions as modulators of multiple myeloma risk and survival
International Journal of Cancer, Vol. 148, Núm. 8, pp. 1887-1894
-
Evaluation of a worldwide EQA scheme for complex clonality analysis of clinical lymphoproliferative cases demonstrates a learning effect
Virchows Archiv, Vol. 479, Núm. 2, pp. 365-376
-
Genetic complexity impacts the clinical outcome of follicular lymphoma patients
Blood Cancer Journal
-
Genetically determined telomere length and multiple myeloma risk and outcome
Blood Cancer Journal, Vol. 11, Núm. 4
-
Liquid biopsy: a non-invasive approach for Hodgkin lymphoma genotyping
British Journal of Haematology, Vol. 195, Núm. 4, pp. 542-551
-
Validation of the EuroClonality-NGS DNA capture panel as an integrated genomic tool for lymphoproliferative disorders
Blood Advances, Vol. 5, Núm. 16, pp. 3188-3198
2020
-
A New Next-Generation Sequencing Strategy for the Simultaneous Analysis of Mutations and Chromosomal Rearrangements at DNA Level in Acute Myeloid Leukemia Patients
Journal of Molecular Diagnostics, Vol. 22, Núm. 1, pp. 60-71
-
Comparison of next-generation sequencing (NGS) and next-generation flow (NGF) for minimal residual disease (MRD) assessment in multiple myeloma
Blood Cancer Journal, Vol. 10, Núm. 10
-
Genomic analysis of a familial myelodysplasia/acute myeloid leukemia and inherited RUNX1 mutations without a pre-existing platelet disorder
Leukemia and Lymphoma
-
Identification of relapse-associated gene mutations by next-generation sequencing in low-risk acute myeloid leukaemia patients
British Journal of Haematology, Vol. 189, Núm. 4, pp. 718-730
-
Molecular profiling of immunoglobulin heavy-chain gene rearrangements unveils new potential prognostic markers for multiple myeloma patients
Blood Cancer Journal, Vol. 10, Núm. 2
-
Reply to Brown et al: ‘Correct application of variant classification guidelines in germline RUNX1 mutated disorders to assist clinical diagnosis’
Leukemia and Lymphoma